Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares. The stock had previously closed at $52.25.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada upgraded shares of Recordati Industria Chimica e Farmaceutica to a “hold” rating in a report on Monday, October 7th.
Get Our Latest Analysis on Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica Price Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last released its earnings results on Tuesday, July 30th. The company reported $0.70 earnings per share for the quarter. The company had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Read More
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Consumer Discretionary Stocks Explained
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.